Analysis of promoter regions of co-expressed genes identified by microarray analysis

od Veerla, Srinivas, Höglund, Mattias
Izdano 2006

Genome-wide transcription factor binding site/promoter databases for the analysis of gene sets and co-occurrence of transcription factor binding motifs

od Veerla, Srinivas, Ringnér, Markus, Höglund, Mattias
Izdano 2010

Constitutional trisomy 8 mosaicism as a model for epigenetic studies of aneuploidy

od Davidsson, Josef, Veerla, Srinivas, Johansson, Bertil
Izdano 2013

Independent component analysis reveals new and biologically significant structures in micro array data

od Frigyesi, Attila, Veerla, Srinivas, Lindgren, David, Höglund, Mattias
Izdano 2006

Molecular subtypes of urothelial carcinoma are defined by specific gene regulatory systems

od Eriksson, Pontus, Aine, Mattias, Veerla, Srinivas, Liedberg, Fredrik, Sjödahl, Gottfrid, Höglund, Mattias
Izdano u BMC Med Genomics (2015)

CYP1A2 – a novel genetic marker for early aromatase inhibitor response in the treatment of breast cancer patients

od Simonsson, Maria, Veerla, Srinivas, Markkula, Andrea, Rose, Carsten, Ingvar, Christian, Jernström, Helena
Izdano u BMC Cancer (2016)

Distinct gene expression signatures in Lynch syndrome and familial colorectal cancer type X

od Valentin, Mev Dominguez, Therkildsen, Cristina, Veerla, Srinivas, Jönsson, Mats, Bernstein, Inge, Nilbert, Mef
Izdano 2013

Integrative epigenomic analysis of differential DNA methylation in urothelial carcinoma

od Aine, Mattias, Sjödahl, Gottfrid, Eriksson, Pontus, Veerla, Srinivas, Lindgren, David, Ringnér, Markus, Höglund, Mattias
Izdano u Genome Med (2015)

Retained Heterodisomy Is Associated with High Gene Expression in Hyperhaploid Inflammatory Leiomyosarcoma

od Nord, Karolin H, Paulsson, Kajsa, Veerla, Srinivas, Wejde, Johan, Brosjö, Otte, Mandahl, Nils, Mertens, Fredrik
Izdano 2012

Distinct Gene Expression Signatures in Lynch Syndrome and Familial Colorectal Cancer Type X

od Dominguez-Valentin, Mev, Therkildsen, Christina, Veerla, Srinivas, Jönsson, Mats, Bernstein, Inge, Borg, Åke, Nilbert, Mef
Izdano 2013

Transcription Factor Binding Site Analysis Identifies FOXO Transcription Factors as Regulators of the Cutaneous Wound Healing Process

od Roupé, Karl Markus, Veerla, Srinivas, Olson, Joshua, Stone, Erica L., Sørensen, Ole E., Hedrick, Stephen M., Nizet, Victor
Izdano 2014

Statin-induced anti-proliferative effects via cyclin D1 and p27 in a window-of-opportunity breast cancer trial

od Feldt, Maria, Bjarnadottir, Olöf, Kimbung, Siker, Jirström, Karin, Bendahl, Pär-Ola, Veerla, Srinivas, Grabau, Dorthe, Hedenfalk, Ingrid, Borgquist, Signe
Izdano u J Transl Med (2015)

Tiling resolution array CGH and high density expression profiling of urothelial carcinomas delineate genomic amplicons and candidate target genes specific for advanced tumors

od Heidenblad, Markus, Lindgren, David, Jonson, Tord, Liedberg, Fredrik, Veerla, Srinivas, Chebil, Gunilla, Gudjonsson, Sigurdur, Borg, Åke, Månsson, Wiking, Höglund, Mattias
Izdano 2008

Genetic and epigenetic characterization of hypodiploid acute lymphoblastic leukemia

od Safavi, Setareh, Olsson, Linda, Biloglav, Andrea, Veerla, Srinivas, Blendberg, Molly, Tayebwa, Johnbosco, Behrendtz, Mikael, Castor, Anders, Hansson, Markus, Johansson, Bertil, Paulsson, Kajsa
Izdano u Oncotarget (2015)

DNA methylation analyses of urothelial carcinoma reveal distinct epigenetic subtypes and an association between gene copy number and methylation status

od Lauss, Martin, Aine, Mattias, Sjödahl, Gottfrid, Veerla, Srinivas, Patschan, Oliver, Gudjonsson, Sigurdur, Chebil, Gunilla, Lövgren, Kristina, Fernö, Mårten, Månsson, Wiking, Liedberg, Fredrik, Ringnér, Markus, Lindgren, David, Höglund, Mattias
Izdano 2012

Assessment of early response biomarkers in relation to long‐term survival in patients with HER2‐negative breast cancer receiving neoadjuvant chemotherapy plus bevacizumab: Results...

od Kimbung, Siker, Markholm, Ida, Bjöhle, Judith, Lekberg, Tobias, von Wachenfeldt, Anna, Azavedo, Edward, Saracco, Ariel, Hellström, Mats, Veerla, Srinivas, Paquet, Eric, Bendahl, Pär‐Ola, Fernö, Mårten, Bergh, Jonas, Loman, Niklas, Hatschek, Thomas, Hedenfalk, Ingrid
Izdano u Int J Cancer (2017)

Distinct mechanisms of resistance to fulvestrant treatment dictate level of ER independence and selective response to CDK inhibitors in metastatic breast cancer

od Kaminska, Kamila, Akrap, Nina, Staaf, Johan, Alves, Carla L., Ehinger, Anna, Ebbesson, Anna, Hedenfalk, Ingrid, Beumers, Lukas, Veerla, Srinivas, Harbst, Katja, Ehmsen, Sidse, Borgquist, Signe, Borg, Åke, Pérez-Fidalgo, Alejandro, Ditzel, Henrik J., Bosch, Ana, Honeth, Gabriella
Izdano u Breast Cancer Res (2021)